Nath Bio-Genes (India) has informed that the 31st AGM of the Members of the Company held on 17th August 2024 at 11:00 am via video conferencing/other audio-visual means. The below mentioned items of the Business Contained in the Notice of Annual General Meeting approved by the Shareholders: Ordinary Business - 1. To receive, consider and adopt the Audited Balance Sheet of the Company as of March 31, 2024, and Statement of Profit & Loss for the year ended as on that date together with the Reports of Directors and Auditors thereon. 2. To declare a Final Dividend of ? 2 per equity shares of face value of ? 10 each for financial year ended 31st March 2024. 3. To appoint Jeevanlata Kagliwal (DIN-02057459) as Director of the Company, who retires by rotation and being eligible, offer herself for re-appointment. All the above resolutions were passed with the requisite majority. Proceedings of AGM, Scrutinizers Report and Voting Results will be uploaded separately.
The above information is a part of company’s filings submitted to BSE.
